1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics 2022 - Northern Europe

Healthcare Analysis & Statistics 2022 - Northern Europe

1-30 of about 100 reports

Spinal Cord Injury - Pipeline Insight, 2021

  • $ 2000
  • September 2021
  • 80 pages

“Spinal Cord Injury - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Spinal Cord Injury pipeline landscape. It covers the pipeline drug ...

  • World
  • Taiwan
  • Neurological Disorder
  • Industry analysis

Persistent Epithelial Defect - Epidemiology forecast- 2030

  • $ 3750
  • August 2021
  • 80 pages

‘Persistent Epithelial Defect (PED)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Persistent Epithelial Defect (PED), historical and forecasted epidemiology in the ...

  • Spain
  • Germany
  • Epidemiology
  • Industry analysis

Anemia - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 150 pages

‘Iron deficiency anemia (IDA)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the IDA across the several selected cancer types, historical and forecasted IDA epidemiology ...

  • Spain
  • France
  • Epidemiology
  • Industry analysis

Major Depressive Disorder - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 175 pages

‘Major Depressive Disorder (MDD)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Major Depressive Disorder (MDD), historical and forecasted epidemiology in the United ...

  • Spain
  • France
  • Depression
  • Industry analysis

Human Papillomavirus 16-positive (HPV16+) Cancers - Epidemiology forecast- 2030

  • $ 3750
  • August 2021
  • 80 pages

‘HPV 16+ Cancer –Epidemiology Forecast—2030’ report delivers an in-depth understanding of HPV 16+ cancer, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, ...

  • France
  • Germany
  • Epidemiology
  • Industry analysis
  • Cancer Incidence

X-Linked Retinitis Pigmentosa (XLRP) - Epidemiology forecast- 2030

  • $ 3750
  • August 2021
  • 68 pages

DelveInsight’s ’X-Linked Retinitis Pigmentosa (XLRP) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted X-Linked Retinitis Pigmentosa ...

  • United States
  • Spain
  • Epidemiology
  • Industry analysis

Functional Dyspepsia - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 64 pages

‘Functional Dyspepsia – Epidemiology Forecast—2030’ report delivers an in-depth understanding of Functional Dyspepsia, historical and forecasted epidemiology in the United States, EU5 (Germany, ...

  • Spain
  • Germany
  • Digestive System Disorder
  • Industry analysis

ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 80 pages

‘ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical and forecasted epidemiology ...

  • United States
  • Spain
  • Breast Cancer
  • Industry analysis

Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology forecast- 2030

  • $ 4750
  • August 2021
  • 180 pages

‘Chronic Obstructive Pulmonary Disease (COPD)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Chronic Obstructive Pulmonary Disease (COPD), historical and forecasted ...

  • United States
  • Spain
  • Respiratory Disease
  • Industry analysis
  • Chronic Obstructive Pulmonary Disease Prevalence

Chronic Hepatitis B Virus Infection - Pipeline Insight, 2021

  • $ 2500
  • July 2021
  • 60 pages

“Chronic Hepatitis B Virus Infection - Pipeline Insight, 2021,” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Chronic Hepatitis B Virus Infection pipeline landscape. ...

  • World
  • United Kingdom
  • Hepatitis
  • Industry analysis

Acute Ischemic Stroke - Pipeline Insight, 2021

  • $ 2000
  • May 2021
  • 60 pages

“Acute Ischemic Stroke – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Acute Ischemic Stroke pipeline landscape. It covers the pipeline ...

  • United Kingdom
  • United States
  • Stroke
  • Industry analysis

Elastomeric Pump - Market Insights, Competitive Landscape and Market Forecast–2026

  • $ 4750
  • May 2021
  • 131 pages

‘Elastomeric Pumps- Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of elastomeric pumps and the historical and forecasted elastomeric pumps ...

  • Spain
  • France
  • Drug Delivery
  • Research And Development
  • Industry analysis

Diabetic Macular Edema (DME) - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 125 pages

‘Diabetic macular edema (DME)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted DME epidemiology in the 7MM, i.e., the United States, ...

  • Japan
  • United States
  • Epidemiology
  • Industry analysis
  • Elderly Population

Glaucoma  - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 156 pages

‘Glaucoma—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Glaucoma , historical and forecasted epidemiology as well as the Glaucoma trends in the United States, EU5 ...

  • Japan
  • Spain
  • Ophthalmology
  • Eye Disease
  • Industry analysis

Sepsis - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 108 pages

‘Sepsis—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Sepsis , historical and forecasted epidemiology as well as the Sepsis trends in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Blood Disease
  • Industry analysis

Heart Failure - Epidemiology forecast- 2030

  • $ 3750
  • May 2021
  • 80 pages

‘Heart Failure (HF)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the HF, historical and forecasted epidemiology as well as the HF trends in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Heart Failure
  • Epidemiology
  • Industry analysis

Microscopic Polyangiitis - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 80 pages

‘Microscopic polyangiitis (MPA) —Epidemiology Forecast–2030’ report delivers an in-depth understanding of the MPA, historical and forecasted epidemiology as well as the MPA epidemiology trends ...

  • Japan
  • Germany
  • Epidemiology
  • Autoimmune Disease
  • Industry analysis
  • Population Size

Age-related Vision Dysfunction - Epidemiology Forecast to 2030

  • $ 5370
  • May 2021
  • 100 pages

‘Age-related Vision Dysfunction - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Age-related Vision Dysfunction epidemiology in the ...

  • United States
  • Japan
  • Epidemiology
  • Ophthalmology
  • Industry analysis
  • Elderly Population

Exocrine Pancreatic Insufficiency (EPI) - Epidemiology Forecast–2030

  • $ 3750
  • April 2021
  • 90 pages

Overview ‘Exocrine Pancreatic Insufficiency (EPI) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Exocrine Pancreatic Insufficiency ...

  • Japan
  • Spain
  • Digestive System Disorder
  • Industry analysis

Postpartum Depression - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 80 pages

‘Postpartum Depression (PPD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Postpartum Depression (PPD) epidemiology in the United ...

  • United States
  • Spain
  • Epidemiology
  • Industry analysis

Tadekinig Alfa- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • April 2021
  • 35 pages

“Tadekinig Alfa- Emerging Insight and Market Forecast – 2030” report provides comprehensive insights about an investigational product for Hemophagocytic Lymphohistiocytosis (HLH): Primary HLH, Secondary ...

  • United States
  • Japan
  • Research And Development
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Diabetic retinopathy - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 90 pages

‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 ...

  • United States
  • Germany
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence

Surgical Site Infection (SSI) - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 70 pages

‘Surgical site infection (SSI)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Surgical site infection (SSI), historical and forecasted epidemiology in the United States, ...

  • United States
  • Italy
  • Infection Control
  • Industry analysis
  • Surgical Procedures Performed

Granulomatosis with Polyangiitis - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 60 pages

‘Granulomatosis with polyangiitis (GPA) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the historical and forecasted epidemiology of GPA in the United States, EU5 ...

  • Germany
  • United States
  • Epidemiology
  • Industry analysis

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030

  • $ 3750
  • March 2021
  • 75 pages

‘EGFR Inhibitors-Induced Skin Disorders- Epidemiology Forecast–2030’ report delivers an in-depth understanding of the EGFR Inhibitors-Induced Skin Disorders historical and forecasted epidemiology ...

  • United States
  • Spain
  • Epidemiology
  • Industry analysis

Glioblastoma multiforme (GBM) - Epidemiology Forecast to 2030

  • $ 3750
  • February 2021
  • 171 pages

‘Glioblastoma Multiforme (GBM) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Glioblastoma Multiforme (GBM) epidemiology in the ...

  • Spain
  • France
  • Brain Cancer
  • Industry analysis

LY3454738- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • February 2021
  • 35 pages

“LY3454738- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Chronic Spontaneous Urticaria in 7 Major Markets. A detailed ...

  • Japan
  • Spain
  • Research And Development
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

Aliqopa - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Aliqopa - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Aliqopa ...

  • Europe
  • Japan
  • Lymphoma
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Acalabrutinib- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“ACALABRUTINIB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

BI 764524 - Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“BI 764524 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure
About 6000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Hospital Demographic Impact in Scotland (UK)

  • January 2022
  • 25 pages
  • Hospital
  • Infectious Disease
  • Industry analysis
  • Hospital Admission
  • Hospital Occupancy Rate

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on